Table 2 Studies report previous diagnoses and preventative treatment of primary headache disorders
Citation | Country/region | Study design/study dates | Criteria | Population (n) | Main findings |
|---|---|---|---|---|---|
Liu R, et al. [4] | China | cross-sectional population-based/2009 | ICHD-2 | 452 individuals with migraine and 531 patients with TTH | 1.13.8% of individuals with migraine and 5.6% of patients with TTH were correctly diagnosed previously |
Katsarava Z, et al. [23] | 10 Europe countries | cross-sectional population-based/2009 | ICHD-2 | 3466 participants with migraine | 1.3.1%-18.0% of individuals with migraine have never seen a doctor 2.1.6%-13.7% of eligible patients in the population-based sample used migraine-preventative medication |
Lipton RB, et al. [16] | US | cross-sectional population-based/2009 | ICHD-2 | 775 individuals with migraine | 1.45.5% of individuals with migraine disorders consulted a health professional in the past year, and 86.7% were diagnosed with migraine |
Li X, et al. [6] | China | cross-sectional neurological clinic/2010 | ICHD-2 | 401 individuals with migraine | 1.13.5% of individuals with migraine had received a physician diagnosis of migraine 2. Only 11 (2.7%) individuals with migraine had used preventative medications |
Lebedeva ER, et al. [18] | Russia | cross-sectional/2012–2013 | ICHD-3β | 1042 students, 1075 workers, and 1007 blood donors | 1.12% of the patients with migraine and 11.7% of patients with TTH had previously been correctly diagnosed 2.0.4% of individuals with migraine and no TTH patients had received prophylactic treatment |
Viana M, et al. [15] | Seven countries | multicentre study/2015–2016 | ICHD-3β | 1161 individuals with migraine | 1. General practitioners misdiagnosed 72% of individuals with migraine 2.29% of patients received at least one migraine preventive medication |
Lipton RB, et al. [17] | US | cross-sectional population-based/2018 | ICHD-3 | 19,888 individuals with migraine | 1.12,905 (61.0%) self-reported a medical diagnosis of migraine 2. 41.6% of those eligible for migraine preventive treatment currently use migraine preventive medication |
Takeshima T, et al. [19] | China, Japan, and South Korea | review/2019 | IHS ICHD-2 ICHD-3β | migraine | 1. In China, 13.5% to 18% of individuals with migraine had been diagnosed with migraine previously 2. In Japan, 11.6% of individuals with migraine were aware that they had migraine 3. There was limited information in South Korea |
Kim BK, et al. [24] | South Korea | multicentre study/2019 | ICHD | 207 participants with migraine | 1. Only 23.7% of individuals with migraine had regularly taken preventive medication |